Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer
Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a “fight-or-flight” response.
A far less familiar mode of cellular transport is the extracellular vesicle (EV). EVs can be thought of as small “chunks” of a cell that are able to pinch off and circulate throughout the body to deliver messenger cargo to other cells. These messengers have become increasingly recognized as crucial mediators of cell-to-cell communication.
In a new study reported in Science Advances, researchers centered at Nagoya University have developed a novel medical device that can efficiently capture these EVs, and potentially use them to screen for cancer.
Video 1: MicroRNA extraction using nanowires
After introducing a urine sample onto the device, extracellular vesicles are captured by a nanowire substrate via electrostatic forces. MicroRNAs can then be directly extracted from the substrate. Takao Yasui
“EVs are potentially useful as clinical markers. The composition of the molecules contained in an EV may provide a diagnostic signature for certain diseases,” lead author Takao Yasui explains. “The ongoing challenge for physicians in any field is to find a non-invasive diagnostic tool that allows them to monitor their patients on a regular basis–for example, a simple urine test.”
Among the many molecules EVs have been found to harbor are microRNAs, which are short pieces of ribonucleic acid that play diverse roles in normal cellular biology. Critically, the presence of certain microRNAs in urine might serve as a red flag for serious conditions such as bladder and prostate cancer. While this important cargo could therefore theoretically aid physicians in cancer diagnoses, there are still many technological hurdles that need to be overcome. One such hurdle: finding a feasible method to capture EVs in sufficient quantities to analyze them in a routine clinical setting.
“The content of EVs in urine is extremely low, at less than 0.01% of the total fluid volume. This is a major barrier to their diagnostic utility,” Yasui notes. Our solution was to embed zinc oxide nanowires into a specialized polymer to create a material that we believed would be highly efficient at capturing these vesicles. Our findings suggest that the device is indeed quite efficient. We obtained a collection rate of over 99%, surpassing ultracentrifugation as well as other methods that are currently being used in the field.”
To test the practicality of their device, the research team compared the microRNAs of EVs isolated from healthy patients with those isolated from patients who were already diagnosed with bladder, prostate, and other forms of cancer. Notably, their technique required only 1 milliliter of urine–far more than the typical “deposit” provided during a routine checkup–and found a substantially greater number and different types of microRNAs compared with the standard ultracentrifugation approach.
Figure 2: Identification of distinct microRNA patterns in healthy donors and cancer patients
Nanowire extraction allowed many microRNAs to be compared at once using urine samples collected from patients. Expression of each microRNA is shown as low/downregulated (blue), intermediate (black), or high/upregulated (yellow). The analysis reveals unique patterns of expression for groups of microRNAs when comparing healthy donors (?) with cancer patients (+). via Takao Yasui
“Finding a specific, reproducible marker to help confirm a cancer diagnosis is difficult. This is especially true for microRNAs, which are a relatively new class of markers in the field,” co-author Yoshinobu Baba explains. “Sometimes finding just one reliable microRNA is considered a success. Using this approach, we were surprised to find that not just one, but whole combinations of microRNAs might be associated with different types of cancers. The findings are preliminary, of course, but we hope our device can help to lay the groundwork for easier ways to diagnose life-threatening diseases as early as possible.”
The Latest on: Detecting cancer
- Local woman encourages others to know family's breast cancer historyon October 14, 2019 at 4:13 am
For most women, an annual mammogram and breast examination may be adequate to ensure early detection for breast cancer, but for women at high risk because of family or other factors, a more ...
- Breast Cancer Awareness Month: Dense breast tissue requires additional screeningon October 14, 2019 at 3:07 am
For these women, additional digital screening options, in addition to mammograms, can lead to better early detection of breast cancer. The Invenia™ ABUS (Automated Breast Ultrasound System), an ...
- San Antonio biotech to invited to join national cancer collaborativeon October 14, 2019 at 3:00 am
Zannes stressed the importance of early lung cancer detection and said there is a "great need" for the company's first product, a noninvasive test for early lung cancer detection, licensed by ...
- Evaluation of integrin αvβ 6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosison October 14, 2019 at 2:08 am
Accumulation of PET tracers in tissues provides a way to image the molecular signature of disease, such as cancer by targeting overexpressed cell surface proteins. Aberrant protein expression also ...
- Staying on Guard Against Skin Canceron October 14, 2019 at 2:00 am
and every hour more than two people die from skin cancer even though it is the cancer everyone can see. No scans or special or invasive detection tests are required, just your eyes or those of a ...
- Mammograms and genetic screening top list for early breast cancer detection in women and menon October 13, 2019 at 5:04 am
Usually testing begins 10 years prior to when an immediate family member, such as a mother or grandmother, was diagnosed with breast cancer. In addition to mammograms, being self-aware of any changes ...
- New UW center awarded NIH funding to improve prevention and detection of canceron October 11, 2019 at 4:22 pm
The creation of these centers are part of NIH's Cancer Moonshot initiative to make more therapies available and improve prevention and detection. One of the six centers will be at the UW. We have ...
- Central Virginia early breast cancer detection group celebrates 17 years of successon October 11, 2019 at 3:34 pm
LYNCHBURG, Va. (WDBJ) -- A Central Virginia group committed to early breast cancer detection is celebrating 17 years of helping women live longer lives. Friday, the group Mammograms Annually A Must (M ...
- WTAE Editorial: Early detection key to fighting breast canceron October 11, 2019 at 9:45 am
WHEN BREAST CANCER IS DETECTED EARLY, IN THE LOCALIZED STAGE, THE 5-YEAR SURVIVAL RATE IS 98%. ACCORDING TO THE AMERICAN CANCER SOCIETY, AN EARLY DETECTION PLAN SHOULD INCLUDE A MONTHLY ...
- Lung cancer screening guidelines do not detect disease among first responderson October 11, 2019 at 9:05 am
Chicago—National lung cancer screening guidelines are inadequate to diagnose patients who contract lung cancer from occupational exposure, including first responders, according to a study reported ...
via Google News and Bing News